Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recurrence × X-Rays × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinosarcoma 2 Brain Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Intraductal Neoplasms 1 Ovarian Neoplasms 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Locally Advanced Cervical Adenocarcinoma 1 Liposarcoma 1 Histiocytoma, Malignant Fibrous 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1 Barrett Esophagus 1 Anus Neoplasms 1 Anal Canal Carcinoma 1 Adenoma, Islet Cell 1

Interventions

Dexamethasone 21 Rituximab 13 Paclitaxel 10 Gemcitabine 10 Cisplatin 10 pomalidomide 9 Lenalidomide 9 Carboplatin 8 Bortezomib 8 Cyclophosphamide 7 Drug Therapy 5 Cytarabine 5 selinexor 4 daratumumab 4 carfilzomib 4 Temozolomide 4 Doxorubicin 4 Docetaxel 4 Bevacizumab 4 Aspirin 4 tisagenlecleucel 3 ibrutinib 3 Vincristine 3 Prednisone 3 Cetuximab 3 Calcium Dobesilate 3 galiximab 2 eculizumab 2 durvalumab 2 blinatumomab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02636634 2016-04-11

CV-METANEC

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡